digital healthupdate: infant measles vaccine faces delay
measles-postponed-because-of-hepatitis-b-component.html
Posted on March 14, 2025 by dr_doctor
According to an article published on March 14, 2025 in the New York Times titled “Infant Measles Vaccine Begins Rollout,” a new vaccine that provides protection against both measles and hepatitis B is meeting with unexpected challenges in the United States. The vaccine, which is expected to offer parents an easier and less expensive way to vaccinate infants, has been delayed due to rare but serious side effects that have emerged in clinical trials, specifically the potential for blood disorders that can be fatal. The delayed vaccine is the second regimen that aims to protect young children against both measles and hepatitis B; the first regimen has already been acknowledged by the World Health Organization as a “contender” for an award for achievements in immunization. The creators of the latest vaccine have stated that they will continue to test the vaccine and seek regulatory approval. The story also quoting a neurosurgeon, Ellad Sirajuddin, who speculates that the delay may result in “unintended consequences,” such as a rise in measles outbreaks.
Leave a Reply